Yahoo
NasdaqCM - Nasdaq Real Time Price USD

INVO Fertility, Inc. (IVF)

1.9100 -0.2344 (-10.93%)
At close: October 30 at 4:00:00 PM EDT
1.9800 +0.0700 (+3.66%)
Pre-Market: 5:40:29 AM EST
Chart Range Bar
Loading chart for IVF
  • Previous Close 2.1444
  • Open 2.0406
  • Bid 0.0550 x 3000
  • Ask 2.0200 x 100
  • Day's Range 1.7190 - 2.2799
  • 52 Week Range 1.5900 - 98.0800
  • Volume 129,432
  • Avg. Volume 540,682
  • Market Cap (intraday) 2.197M
  • Beta (5Y Monthly) 1.61
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 511.8000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 80.00

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

www.invofertility.com

40

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IVF
87.32%
S&P 500 (^GSPC)
10.73%

1-Year Return

IVF
97.41%
S&P 500 (^GSPC)
11.11%

3-Year Return

IVF
99.97%
S&P 500 (^GSPC)
81.91%

5-Year Return

IVF
100.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.18M
Earnings 888.74k
Profit Margin 40.85%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-4M
-2M
0
2M
-200.0%
-100.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

80.00
80.00 Average
1.9100 Current
80.00 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -92.30%

  • Return on Assets (ttm)

    -16.41%

  • Return on Equity (ttm)

    -72.70%

  • Revenue (ttm)

    7.53M

  • Net Income Avi to Common (ttm)

    -8.76M

  • Diluted EPS (ttm)

    511.8000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.73M

  • Total Debt/Equity (mrq)

    23.78%

  • Levered Free Cash Flow (ttm)

    -5.35M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: